40.16% Less UCB S A ORDINARY SHARES BELGIUM (OTCMKTS:UCBJF) Short Interest

June 27, 2018 - By Ronnie Lemelle

UCB SA (OTCMKTS:UCBJF) Corporate Logo

UCB S A ORDINARY SHARES BELGIUM (OTCMKTS:UCBJF) had a decrease of its short interest by 40.16%. It was announced in June by FINRA the 123,800 short interest on UCBJF. The down change of 40.16% from 206,900 shares was reported. With Average volume 200, UCBJF’s former position will take 619 days to restore. Float short on UCB S A ORDINARY SHARES BELGIUM is 0.11%.

$78.18 was the last price.It’s since June 27, 2017 and is 0.00% down. UCBJF underperformed the S&P 500 by 12.57%.

UCB SA, a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system.The firm is worth $14.94 billion. The Company’s core products include Cimzia for ankylosing spondylitis, axial spondyloarthritis, Crohn??s disease, psoriatic arthritis, and rheumatoid arthritis; Keppra, Vimpat, and Briviact for epilepsy; and Neupro for Parkinson??s disease and restless legs syndrome.16.86 is the P/E ratio. The firm also offers Zyrtec and Xyzal for allergy; Venlafaxine ER for depressive and anxiety disorders; Nootropil for cognitive disorders; and Xyrem for narcolepsy.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.